The U.K.'s Acambis has won a $425 million contract to supply the CDC with its smallpox vaccine for 10 years. Acambis will establish a U.S.-based manufacturing capability for ACAM2000 and deliver a minimum of nine million doses per year of the drug. "The net proceeds will enable us to invest in manufacturing facilities for the U.S. contract, progress our vaccine for hospital-acquired C.difficile infections and further our program of new vaccines against influenza, genital herpes and other significant unmet medical needs," Acambis head Ian Garland told ShareCast.
- see the Acambis release
- read this reportÂ from ShareCast
Sanofi buys into Acambis' West Nile vaccine program
Acambis' universal vaccine begins human clinical trials
Acambis shares plunge after U.S. nixes contract
Acambis completes vaccine BLA
Acambis researching single-shot solution to flu